“With more than 25 years of corporate, legal and business development experience in the life sciences industry, Richard is a well-respected and recognized practitioner who brings to Goodwin a unique mix of diverse and significant professional expertise and a deep network in New England and beyond,” said Mitchell Bloom, Chair of Goodwin’s Life Sciences Practice. “We are thrilled to welcome Richard to our highly collaborative life sciences team and we look forward to partnering with him as we continue to provide best-in-class life cycle support to our biotechnology, pharmaceutical and medical technology clients.”
Hoffman’s extensive life sciences industry experience includes establishing new companies, negotiating and closing venture capital financings, in-licensing technologies, and developing and implementing corporate and business development strategies. He has a successful track record in structuring, negotiating and documenting strategic deals with both public and private companies.
Hoffman joins Goodwin from WilmerHale, where he was an associate and then a junior partner from 1987 through 1994, and a partner from 2013. He also served as a legal adviser and a business consultant to numerous biotechnology companies.
Hoffman earned his J.D. from Columbia Law School, his MBA from The Wharton School, University of Pennsylvania and his B.A. in Biochemical Sciences (magna cum laude) from Harvard College. He is a member of the Massachusetts, Maryland and District of Columbia Bar Associations.
Hoffman can be reached at firstname.lastname@example.org or (617) 570-1072.
Goodwin’s Life Sciences Practice is among the leading practices in the United States, with more than 100 experienced life sciences attorneys. Its full-service team serves all legal needs of life sciences clients from corporate and partnering to intellectual property, regulatory and litigation. Goodwin was named U.S. News-Best Lawyers’ “Law Firm of the Year” in Biotechnology Law for three consecutive years (2013-2015). Clients include more than 400 private and public life sciences companies and their investors, from start-ups and Fortune 100 corporations to venture capital funds and investment banks.
At Goodwin, we use law to achieve unprecedented results for our clients. Our 900 plus lawyers across the United States, Europe and Asia excel at complex transactions, high-stakes litigations and world-class advisory services in the financial, life sciences, private equity, real estate and technology industries. We partner with our clients to practice law with integrity, ingenuity, agility and ambition. To learn more, visit us at www.goodwinlaw.com and follow us on Twitter at @goodwinlaw and on LinkedIn.